Circulating anti-entactin antibodies in patients with glomerulonephritis

Ramesh Saxena, Per Bygren, Bo Cederholm, Jörgen Wieslander

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Sera from 305 consecutive patients in a renal biopsy series were analyzed for the presence of anti-entactin antibodies by ELISA. Of these patients, 59% had primary glomerulonephritis, 21% had secondary glomerulonephritis. while 20% had other nephropathies (non-inflammatory conditions like amyloidosis. diabetic nephropathy, nephrosclerosis, etc.). Forty-one of these patients (13.4%) were positive for IgG/IgM antibodies against entactin; 60% of them had primary glomerulonephritis, 35% had secondary glomerulonephritis, while the remaining 3 patients had other nephropathies. Fifteen (70%) of the 23 patients with primary glomerulonephritis had proliferative glomerulonephritis (PGN), whereas 13 (87%) of the 15 patients with secondary glomerulonephritis were due to systemic connective tissue diseases (SCTD); 7 due to SLE, 4 due to SLE like SCTD and two due to other SCTD. There was a peak of incidence corresponding to the group aged 18 to 30 years. A majority of these patients (12 of the total 17) had primary glomerulonephritis and were associated with nephrotic or subnephrotic grade proteinuria, poorly or nonresponsive to immunosuppressive treatment and associated, in several cases, with progressive deterioration of renal function. In addition, there was a tendency to another peak in the age group 51 to 60 years. Most of these patients (6 of the total 8) had glomerulonephritis secondary, mainly, to SLE or SLE like SCTD with milder degree of proteinuria and better preserved renal functions. Anti-entactin antibodies were not found in certain glomerulonephritides like IgA nephropathy and those secondary to systemic vasculitides and in control subjects (healthy subjects, and patients with a variety of non-renal disorders including inflammatory diseases). There was a significant correlation between the presence of circulating anti-entactin antibodies and the deposition of corresponding class of immunoglobulin along the glomerular basement membrane. In addition, a significant correlation between the absence of immune deposits and negative results for anti-entactin antibodies by ELISA was also observed. Our observations suggest that anti-entactin antibodies are associated with certain definite categories of glomerulonephritides in human beings and may well be involved in their immunopathogenesis.

Original languageEnglish (US)
Pages (from-to)996-1004
Number of pages9
JournalKidney International
Volume39
Issue number5
StatePublished - May 1991

Fingerprint

Glomerulonephritis
Anti-Idiotypic Antibodies
Connective Tissue Diseases
Kidney
Proteinuria
nidogen
Enzyme-Linked Immunosorbent Assay
Nephrosclerosis
Systemic Vasculitis
Glomerular Basement Membrane
Immunoglobulin Isotypes
Diabetic Nephropathies
Amyloidosis
Immunosuppressive Agents
Immunoglobulin A
Immunoglobulin M
Healthy Volunteers
Age Groups
Immunoglobulin G
Biopsy

ASJC Scopus subject areas

  • Nephrology

Cite this

Saxena, R., Bygren, P., Cederholm, B., & Wieslander, J. (1991). Circulating anti-entactin antibodies in patients with glomerulonephritis. Kidney International, 39(5), 996-1004.

Circulating anti-entactin antibodies in patients with glomerulonephritis. / Saxena, Ramesh; Bygren, Per; Cederholm, Bo; Wieslander, Jörgen.

In: Kidney International, Vol. 39, No. 5, 05.1991, p. 996-1004.

Research output: Contribution to journalArticle

Saxena, R, Bygren, P, Cederholm, B & Wieslander, J 1991, 'Circulating anti-entactin antibodies in patients with glomerulonephritis', Kidney International, vol. 39, no. 5, pp. 996-1004.
Saxena R, Bygren P, Cederholm B, Wieslander J. Circulating anti-entactin antibodies in patients with glomerulonephritis. Kidney International. 1991 May;39(5):996-1004.
Saxena, Ramesh ; Bygren, Per ; Cederholm, Bo ; Wieslander, Jörgen. / Circulating anti-entactin antibodies in patients with glomerulonephritis. In: Kidney International. 1991 ; Vol. 39, No. 5. pp. 996-1004.
@article{3d74aeeb55374f73a2c3807079690076,
title = "Circulating anti-entactin antibodies in patients with glomerulonephritis",
abstract = "Sera from 305 consecutive patients in a renal biopsy series were analyzed for the presence of anti-entactin antibodies by ELISA. Of these patients, 59{\%} had primary glomerulonephritis, 21{\%} had secondary glomerulonephritis. while 20{\%} had other nephropathies (non-inflammatory conditions like amyloidosis. diabetic nephropathy, nephrosclerosis, etc.). Forty-one of these patients (13.4{\%}) were positive for IgG/IgM antibodies against entactin; 60{\%} of them had primary glomerulonephritis, 35{\%} had secondary glomerulonephritis, while the remaining 3 patients had other nephropathies. Fifteen (70{\%}) of the 23 patients with primary glomerulonephritis had proliferative glomerulonephritis (PGN), whereas 13 (87{\%}) of the 15 patients with secondary glomerulonephritis were due to systemic connective tissue diseases (SCTD); 7 due to SLE, 4 due to SLE like SCTD and two due to other SCTD. There was a peak of incidence corresponding to the group aged 18 to 30 years. A majority of these patients (12 of the total 17) had primary glomerulonephritis and were associated with nephrotic or subnephrotic grade proteinuria, poorly or nonresponsive to immunosuppressive treatment and associated, in several cases, with progressive deterioration of renal function. In addition, there was a tendency to another peak in the age group 51 to 60 years. Most of these patients (6 of the total 8) had glomerulonephritis secondary, mainly, to SLE or SLE like SCTD with milder degree of proteinuria and better preserved renal functions. Anti-entactin antibodies were not found in certain glomerulonephritides like IgA nephropathy and those secondary to systemic vasculitides and in control subjects (healthy subjects, and patients with a variety of non-renal disorders including inflammatory diseases). There was a significant correlation between the presence of circulating anti-entactin antibodies and the deposition of corresponding class of immunoglobulin along the glomerular basement membrane. In addition, a significant correlation between the absence of immune deposits and negative results for anti-entactin antibodies by ELISA was also observed. Our observations suggest that anti-entactin antibodies are associated with certain definite categories of glomerulonephritides in human beings and may well be involved in their immunopathogenesis.",
author = "Ramesh Saxena and Per Bygren and Bo Cederholm and J{\"o}rgen Wieslander",
year = "1991",
month = "5",
language = "English (US)",
volume = "39",
pages = "996--1004",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Circulating anti-entactin antibodies in patients with glomerulonephritis

AU - Saxena, Ramesh

AU - Bygren, Per

AU - Cederholm, Bo

AU - Wieslander, Jörgen

PY - 1991/5

Y1 - 1991/5

N2 - Sera from 305 consecutive patients in a renal biopsy series were analyzed for the presence of anti-entactin antibodies by ELISA. Of these patients, 59% had primary glomerulonephritis, 21% had secondary glomerulonephritis. while 20% had other nephropathies (non-inflammatory conditions like amyloidosis. diabetic nephropathy, nephrosclerosis, etc.). Forty-one of these patients (13.4%) were positive for IgG/IgM antibodies against entactin; 60% of them had primary glomerulonephritis, 35% had secondary glomerulonephritis, while the remaining 3 patients had other nephropathies. Fifteen (70%) of the 23 patients with primary glomerulonephritis had proliferative glomerulonephritis (PGN), whereas 13 (87%) of the 15 patients with secondary glomerulonephritis were due to systemic connective tissue diseases (SCTD); 7 due to SLE, 4 due to SLE like SCTD and two due to other SCTD. There was a peak of incidence corresponding to the group aged 18 to 30 years. A majority of these patients (12 of the total 17) had primary glomerulonephritis and were associated with nephrotic or subnephrotic grade proteinuria, poorly or nonresponsive to immunosuppressive treatment and associated, in several cases, with progressive deterioration of renal function. In addition, there was a tendency to another peak in the age group 51 to 60 years. Most of these patients (6 of the total 8) had glomerulonephritis secondary, mainly, to SLE or SLE like SCTD with milder degree of proteinuria and better preserved renal functions. Anti-entactin antibodies were not found in certain glomerulonephritides like IgA nephropathy and those secondary to systemic vasculitides and in control subjects (healthy subjects, and patients with a variety of non-renal disorders including inflammatory diseases). There was a significant correlation between the presence of circulating anti-entactin antibodies and the deposition of corresponding class of immunoglobulin along the glomerular basement membrane. In addition, a significant correlation between the absence of immune deposits and negative results for anti-entactin antibodies by ELISA was also observed. Our observations suggest that anti-entactin antibodies are associated with certain definite categories of glomerulonephritides in human beings and may well be involved in their immunopathogenesis.

AB - Sera from 305 consecutive patients in a renal biopsy series were analyzed for the presence of anti-entactin antibodies by ELISA. Of these patients, 59% had primary glomerulonephritis, 21% had secondary glomerulonephritis. while 20% had other nephropathies (non-inflammatory conditions like amyloidosis. diabetic nephropathy, nephrosclerosis, etc.). Forty-one of these patients (13.4%) were positive for IgG/IgM antibodies against entactin; 60% of them had primary glomerulonephritis, 35% had secondary glomerulonephritis, while the remaining 3 patients had other nephropathies. Fifteen (70%) of the 23 patients with primary glomerulonephritis had proliferative glomerulonephritis (PGN), whereas 13 (87%) of the 15 patients with secondary glomerulonephritis were due to systemic connective tissue diseases (SCTD); 7 due to SLE, 4 due to SLE like SCTD and two due to other SCTD. There was a peak of incidence corresponding to the group aged 18 to 30 years. A majority of these patients (12 of the total 17) had primary glomerulonephritis and were associated with nephrotic or subnephrotic grade proteinuria, poorly or nonresponsive to immunosuppressive treatment and associated, in several cases, with progressive deterioration of renal function. In addition, there was a tendency to another peak in the age group 51 to 60 years. Most of these patients (6 of the total 8) had glomerulonephritis secondary, mainly, to SLE or SLE like SCTD with milder degree of proteinuria and better preserved renal functions. Anti-entactin antibodies were not found in certain glomerulonephritides like IgA nephropathy and those secondary to systemic vasculitides and in control subjects (healthy subjects, and patients with a variety of non-renal disorders including inflammatory diseases). There was a significant correlation between the presence of circulating anti-entactin antibodies and the deposition of corresponding class of immunoglobulin along the glomerular basement membrane. In addition, a significant correlation between the absence of immune deposits and negative results for anti-entactin antibodies by ELISA was also observed. Our observations suggest that anti-entactin antibodies are associated with certain definite categories of glomerulonephritides in human beings and may well be involved in their immunopathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0025729382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025729382&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 996

EP - 1004

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -